Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
General Information
Version
03/16/2017
Revision date
2017-03-16
Product name
Magnesium Sulfate Injection, USP
Product name
Magnesium Sulfate Injection, USP
Identification on the label/Trade name
Magnesium Sulfate Injection, USP | Manufacturer Fresenius Kabi USA LLC
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H335, H360, H362
Hazard statements
Code
Statements
H335
May cause respiratory irritation
Section 2
Signal word
DANGER. GHS Class Reproductive toxicity. Category 1A. Specific Target Organ Toxicity - STOT, Single Exposure SE. Category 3 (CNS). Reproductive toxicity. Effects on or via lactation.
Hazard statements
May damage fertility or the unborn child. May cause respiratory irritation. May cause harm to breast-fed children.
Precautionary statements
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Avoid breathing dust/fume/gas/mist/vapours/spray. Avoid contact during pregnancy and while nursing. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Wear protective gloves/protective clothing/eye protection/face protection. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. IF exposed or concerned: Get medical advice/attention. Call a POISON CENTER or doctor/physician if you feel unwell. Store in a well-ventilated place. Keep container tightly closed. Store locked up. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye: Skin Contact with eyes may cause irritation. May cause skin irritation. Inhalation May cause irritation of respiratory tract. Ingestion May cause irritation. Signs/Symptoms Adverse reactions from prescribed doses include: magnesium toxicity (flushing, sweating, hypotension, depressed reflexes, flaccid paralysis, hypothermia, circulatory collapse, cardiac and CNS depression proceeding to respiratory paralysis) and hypocalcemia with signs of tetany. Magnesium intoxication is manifested by a sharp drop in blood pressure and respiratory paralysis. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing By Accidental Exposure: Individuals with heart block or myocardial damage. Conditions
